The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Immune Repertoire Sequencing-Global Market Insights and Sales Trends 2024
Synopsis
Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portrays as the antigen-specific information within lymphocytes and has become increasingly significant to understand body’s autoimmunity and healthy immunity. This also propose novel ways to tackle cancer and development of personalized medicine by understanding the genetic makeup of a person. Since the last two decades, the technical advancements in the high throughput sequencing techniques along with the development in the bioinformatics and statistical tools have made the immune repertoire sequencing to be analyzed at single sequence level. This technology has potential to explore for the novel infectious agents and also offers new approaches for vaccine or antibody development.
The global Immune Repertoire Sequencing market size is expected to reach US$ 128.8 million by 2029, growing at a CAGR of 3.2% from 2023 to 2029. The market is mainly driven by the significant applications of Immune Repertoire Sequencing in various end use industries. The expanding demands from the Bioinformatics, Hematology, Immunology and Others, are propelling Immune Repertoire Sequencing market. Pyro-Sequencing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dye-Terminating Sequencing segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Immune Repertoire Sequencing market, driven by demand from China, the second largest economy with some signs of stabilising, the Immune Repertoire Sequencing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immune Repertoire Sequencing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immune Repertoire Sequencing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immune Repertoire Sequencing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immune Repertoire Sequencing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immune Repertoire Sequencing covered in this report include Adaptive Biotechnologies & Amgen, BGI, Alacris Theranostics, CD Genomics, AptaIT, ArcherDX, Roche Holding and ThermoFisher Scietific, etc.
The global Immune Repertoire Sequencing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Adaptive Biotechnologies & Amgen
BGI
Alacris Theranostics
CD Genomics
AptaIT
ArcherDX
Roche Holding
ThermoFisher Scietific
Global Immune Repertoire Sequencing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immune Repertoire Sequencing market, Segment by Type:
Pyro-Sequencing
Dye-Terminating Sequencing
Others
Global Immune Repertoire Sequencing market, by Application
Bioinformatics
Hematology
Immunology
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immune Repertoire Sequencing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portrays as the antigen-specific information within lymphocytes and has become increasingly significant to understand body’s autoimmunity and healthy immunity. This also propose novel ways to tackle cancer and development of personalized medicine by understanding the genetic makeup of a person. Since the last two decades, the technical advancements in the high throughput sequencing techniques along with the development in the bioinformatics and statistical tools have made the immune repertoire sequencing to be analyzed at single sequence level. This technology has potential to explore for the novel infectious agents and also offers new approaches for vaccine or antibody development.
The global Immune Repertoire Sequencing market size is expected to reach US$ 128.8 million by 2029, growing at a CAGR of 3.2% from 2023 to 2029. The market is mainly driven by the significant applications of Immune Repertoire Sequencing in various end use industries. The expanding demands from the Bioinformatics, Hematology, Immunology and Others, are propelling Immune Repertoire Sequencing market. Pyro-Sequencing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dye-Terminating Sequencing segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Immune Repertoire Sequencing market, driven by demand from China, the second largest economy with some signs of stabilising, the Immune Repertoire Sequencing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immune Repertoire Sequencing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immune Repertoire Sequencing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immune Repertoire Sequencing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immune Repertoire Sequencing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immune Repertoire Sequencing covered in this report include Adaptive Biotechnologies & Amgen, BGI, Alacris Theranostics, CD Genomics, AptaIT, ArcherDX, Roche Holding and ThermoFisher Scietific, etc.
The global Immune Repertoire Sequencing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Adaptive Biotechnologies & Amgen
BGI
Alacris Theranostics
CD Genomics
AptaIT
ArcherDX
Roche Holding
ThermoFisher Scietific
Global Immune Repertoire Sequencing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immune Repertoire Sequencing market, Segment by Type:
Pyro-Sequencing
Dye-Terminating Sequencing
Others
Global Immune Repertoire Sequencing market, by Application
Bioinformatics
Hematology
Immunology
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immune Repertoire Sequencing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Immune Repertoire Sequencing
1.1 Immune Repertoire Sequencing Market Overview
1.1.1 Immune Repertoire Sequencing Product Scope
1.1.2 Immune Repertoire Sequencing Market Status and Outlook
1.2 Global Immune Repertoire Sequencing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Immune Repertoire Sequencing Market Size by Region (2018-2029)
1.4 Global Immune Repertoire Sequencing Historic Market Size by Region (2018-2023)
1.5 Global Immune Repertoire Sequencing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Immune Repertoire Sequencing Market Size (2018-2029)
1.6.1 North America Immune Repertoire Sequencing Market Size (2018-2029)
1.6.2 Europe Immune Repertoire Sequencing Market Size (2018-2029)
1.6.3 Asia-Pacific Immune Repertoire Sequencing Market Size (2018-2029)
1.6.4 Latin America Immune Repertoire Sequencing Market Size (2018-2029)
1.6.5 Middle East & Africa Immune Repertoire Sequencing Market Size (2018-2029)
2 Immune Repertoire Sequencing Market by Type
2.1 Introduction
2.1.1 Pyro-Sequencing
2.1.2 Dye-Terminating Sequencing
2.1.3 Others
2.2 Global Immune Repertoire Sequencing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Immune Repertoire Sequencing Historic Market Size by Type (2018-2023)
2.2.2 Global Immune Repertoire Sequencing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Immune Repertoire Sequencing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Immune Repertoire Sequencing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Immune Repertoire Sequencing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Immune Repertoire Sequencing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Immune Repertoire Sequencing Revenue Breakdown by Type (2018-2029)
3 Immune Repertoire Sequencing Market Overview by Application
3.1 Introduction
3.1.1 Bioinformatics
3.1.2 Hematology
3.1.3 Immunology
3.1.4 Others
3.2 Global Immune Repertoire Sequencing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Immune Repertoire Sequencing Historic Market Size by Application (2018-2023)
3.2.2 Global Immune Repertoire Sequencing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Immune Repertoire Sequencing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Immune Repertoire Sequencing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Immune Repertoire Sequencing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Immune Repertoire Sequencing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Immune Repertoire Sequencing Revenue Breakdown by Application (2018-2029)
4 Immune Repertoire Sequencing Competition Analysis by Players
4.1 Global Immune Repertoire Sequencing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immune Repertoire Sequencing as of 2022)
4.3 Date of Key Players Enter into Immune Repertoire Sequencing Market
4.4 Global Top Players Immune Repertoire Sequencing Headquarters and Area Served
4.5 Key Players Immune Repertoire Sequencing Product Solution and Service
4.6 Competitive Status
4.6.1 Immune Repertoire Sequencing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Adaptive Biotechnologies & Amgen
5.1.1 Adaptive Biotechnologies & Amgen Profile
5.1.2 Adaptive Biotechnologies & Amgen Main Business
5.1.3 Adaptive Biotechnologies & Amgen Immune Repertoire Sequencing Products, Services and Solutions
5.1.4 Adaptive Biotechnologies & Amgen Immune Repertoire Sequencing Revenue (US$ Million) & (2018-2023)
5.1.5 Adaptive Biotechnologies & Amgen Recent Developments
5.2 BGI
5.2.1 BGI Profile
5.2.2 BGI Main Business
5.2.3 BGI Immune Repertoire Sequencing Products, Services and Solutions
5.2.4 BGI Immune Repertoire Sequencing Revenue (US$ Million) & (2018-2023)
5.2.5 BGI Recent Developments
5.3 Alacris Theranostics
5.3.1 Alacris Theranostics Profile
5.3.2 Alacris Theranostics Main Business
5.3.3 Alacris Theranostics Immune Repertoire Sequencing Products, Services and Solutions
5.3.4 Alacris Theranostics Immune Repertoire Sequencing Revenue (US$ Million) & (2018-2023)
5.3.5 CD Genomics Recent Developments
5.4 CD Genomics
5.4.1 CD Genomics Profile
5.4.2 CD Genomics Main Business
5.4.3 CD Genomics Immune Repertoire Sequencing Products, Services and Solutions
5.4.4 CD Genomics Immune Repertoire Sequencing Revenue (US$ Million) & (2018-2023)
5.4.5 CD Genomics Recent Developments
5.5 AptaIT
5.5.1 AptaIT Profile
5.5.2 AptaIT Main Business
5.5.3 AptaIT Immune Repertoire Sequencing Products, Services and Solutions
5.5.4 AptaIT Immune Repertoire Sequencing Revenue (US$ Million) & (2018-2023)
5.5.5 AptaIT Recent Developments
5.6 ArcherDX
5.6.1 ArcherDX Profile
5.6.2 ArcherDX Main Business
5.6.3 ArcherDX Immune Repertoire Sequencing Products, Services and Solutions
5.6.4 ArcherDX Immune Repertoire Sequencing Revenue (US$ Million) & (2018-2023)
5.6.5 ArcherDX Recent Developments
5.7 Roche Holding
5.7.1 Roche Holding Profile
5.7.2 Roche Holding Main Business
5.7.3 Roche Holding Immune Repertoire Sequencing Products, Services and Solutions
5.7.4 Roche Holding Immune Repertoire Sequencing Revenue (US$ Million) & (2018-2023)
5.7.5 Roche Holding Recent Developments
5.8 ThermoFisher Scietific
5.8.1 ThermoFisher Scietific Profile
5.8.2 ThermoFisher Scietific Main Business
5.8.3 ThermoFisher Scietific Immune Repertoire Sequencing Products, Services and Solutions
5.8.4 ThermoFisher Scietific Immune Repertoire Sequencing Revenue (US$ Million) & (2018-2023)
5.8.5 ThermoFisher Scietific Recent Developments
6 North America
6.1 North America Immune Repertoire Sequencing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Immune Repertoire Sequencing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Immune Repertoire Sequencing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Immune Repertoire Sequencing Market Dynamics
11.1 Immune Repertoire Sequencing Industry Trends
11.2 Immune Repertoire Sequencing Market Drivers
11.3 Immune Repertoire Sequencing Market Challenges
11.4 Immune Repertoire Sequencing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
